From the report: ’ ’   Valeant is not the only company that could get hit if the   interest deduction is eliminated. There are a number of companies   with this structure, including Mylan, the now infamous maker of   EpiPen medication. ’ "    There’s no telling how Congress will handle these companies once   new legislation is passed and there’s a transitional phase as   American companies adjust. 